IBRUTINIB TABLETS
Zydus Lifesciences gets tentative nod from USFDA for generic blood cancer drugZydus Lifesciences received tentative USFDA approval for its generic Ibrutinib tablets, used to treat various blood cancers like CLL/SLL an...
Zydus Cadila gets tentative nod from USFDA to market cancer drug"Ibrutinib belongs to a class of drugs known as kinase inhibitors and is used to treat certain cancers, such as mantle cell lymphoma or mar...
Zydus Cadila gets USFDA nod for cancer and high blood pressure, treatment drugZydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Ibrutinib Capsules in the strengths of ...
Natco launches cut price versions of cancer drug ibrutinib in indiaThe patent for the drug is held by Pharmacyclics for three to four more years in India. Pharmacyclics was globally acquired by US giant Abb...
Illegal cancer drugs from Bangladesh flood local marketIllegal import of drugs from Bangladesh and other neighbouring countries have further added to the woes of pharmaceutical companies. Expert...
Load More